The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...

Dietary iron deficiency in mice alters lung T cell activation during influenza infection and leads to memory T cells that are ...

Scientists have long known that bacteria come in many shapes and sizes, but understanding what those differences mean has ...

The SAVE regimen achieved an 86% ORR in newly diagnosed AML, with high MRD-negative rates, especially in NPM1 mutations or KMT2A rearrangements. Significant myelosuppression and infectious ...

Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by ...

CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive ...

Jones anchored her discussion in a core philosophy for veterinary oncology: "one size does not fit all.” According to Jones, ...

The work grew out of decades of prostate cancer research by Michael Shen, PhD, co-leader of the Tumor Biology and ...

Key points A 62-year-old man with hypertension and chronic renal disease presented to an emergency department with abdominal pain and chills. His vital signs were normal except for high blood pressure ...

Laser scanning cytometry (LSC) is the technology of choice for automated, quantitative high-content, high-throughput analysis of heterogeneous cellular samples and tissue specimens. LSC complements ...

MRD negativity post-chemotherapy strongly predicts improved overall survival in AML, with a significant reduction in mortality risk. The study suggests MRD could serve as an earlier surrogate endpoint ...